Literature DB >> 16231756

Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects.

Yasuaki Saijo1, Megumi Utsugi, Eiji Yoshioka, Naoko Horikawa, Tetsuro Sato, Yingyan Gong, Reiko Kishi.   

Abstract

Beta2-Microglobulin (beta2m) is related to inflammatory diseases, but there have been few reports of a relationship between beta2m and atherosclerosis. We have examined the influence of beta2m on brachial-ankle pulse wave velocity (baPWV) to clarify whether it is related to arterial stiffness. baPWV, beta2m, C-reactive protein (CRP), and conventional risk factors were measured in 614 males and 158 females. The adjusted means of baPWV were compared with the quartiles of beta2m, and significant differences in baPWV were observed across the quartiles of beta2m (p = 0.037). After being adjusted for potential confounders, quartile 4 of beta2m, quartile 4 of CRP, and the combination of high beta2m plus high CRP were significantly associated with a high value of PWV (quartile 4 of beta2m: odds ratio [OR] 2.53, 95% confidence interval [CI], 1.31-4.89; quartile 4 of CRP: OR 2.27, 95% CI, 1.18-4.34; high beta2m plus high CRP: OR 5.60, 95% CI, 2.38-13.2). These results suggest that beta2m is associated with an increase of arterial stiffness. Further studies are needed to clarify whether beta2m is related to atherosclerotic diseases, and whether the combination of beta2m and CRP measurement is a useful predictor for the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231756     DOI: 10.1291/hypres.28.505

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  14 in total

Review 1.  Role of β2-microglobulin in uremic patients may be greater than originally suspected.

Authors:  Aysegul Zumrutdal
Journal:  World J Nephrol       Date:  2015-02-06

2.  Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population.

Authors:  Yasuaki Saijo; Megumi Utsugi; Eiji Yoshioka; Tomonori Fukui; Fumihiro Sata; Naoki Nakagawa; Naoyuki Hasebe; Takahiko Yoshida; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2009-03-17       Impact factor: 3.674

Review 3.  Biomarkers and Genetics in Peripheral Artery Disease.

Authors:  Surovi Hazarika; Brian H Annex
Journal:  Clin Chem       Date:  2016-11-21       Impact factor: 8.327

Review 4.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

5.  Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling.

Authors:  Ross L Prentice; Sophie Paczesny; Aaron Aragaki; Lynn M Amon; Lin Chen; Sharon J Pitteri; Martin McIntosh; Pei Wang; Tina Buson Busald; Judith Hsia; Rebecca D Jackson; Jacques E Rossouw; Joann E Manson; Karen Johnson; Charles Eaton; Samir M Hanash
Journal:  Genome Med       Date:  2010-07-28       Impact factor: 11.117

6.  A biomarker panel for peripheral arterial disease.

Authors:  Eric T Fung; Andrew M Wilson; Fujun Zhang; Nathan Harris; Kim A Edwards; Jeffrey W Olin; John P Cooke
Journal:  Vasc Med       Date:  2008-08       Impact factor: 3.239

7.  Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Authors:  Meredith C Foster; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; John Eckfeldt; Stephen P Juraschek; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-03-19       Impact factor: 8.860

8.  Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.

Authors:  Motoshi Ouchi; Kenzo Oba; Taro Saigusa; Kentaro Watanabe; Makoto Ohara; Noriaki Matsumura; Tatsuya Suzuki; Naohiko Anzai; Shuichi Tsuruoka; Masahiro Yasutake
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-09       Impact factor: 3.738

9.  Association between plasma Beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease.

Authors:  Omid Sedighi; Saeid Abediankenari; Batoul Omranifar
Journal:  Nephrourol Mon       Date:  2014-12-07

10.  Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.

Authors:  Ross L Prentice; Shanshan Zhao; Melissa Johnson; Aaron Aragaki; Judith Hsia; Rebecca D Jackson; Jacques E Rossouw; JoAnn E Manson; Samir M Hanash
Journal:  Genome Med       Date:  2013-12-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.